Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Kanamycin
DRUG
4 trials
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
, IUATLD, Inc
, University of Cape Town
Conditions
Extensively-drug Resistant Tuberculosis
HIV Infections
MDR-TB
Multidrug Resistant Tuberculosis
Tuberculosis
Phase 1
Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis
Completed
NCT00816426
National Institute of Allergy and Infectious Diseases (NIAID)
Tuberculosis
Start: 2008-12-29
End: 2017-12-29
Updated: 2019-12-09
Phase 2
An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis
Completed
NCT02454205
University of Cape Town
Extensively-drug Resistant Tuberculosis, Multidrug Resistant Tuberculosis, Tuberculosis
Start: 2015-11-12
End: 2021-08-30
Updated: 2021-09-29
Phase 3
The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB
Completed
NCT02409290
IUATLD, Inc
MDR-TB
Start: 2016-03-31
End: 2023-05-02
Updated: 2023-09-28
Unknown Phase
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Completed
NCT00042289
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
Start: 2003-06-09
End: 2020-09-30
Updated: 2025-12-02
Related Papers
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen
Nature Communications
2024-08-25
12 citations
T-wave morphology abnormalities in the STREAM stage 1 trial
Expert Opinion on Drug Safety
2024-03-10
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)
American Journal of Respiratory and Critical Care Medicine
2022-02-17
86 citations
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.
2021-09-25
22 citations
Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate.
2021-02-17
17 citations
Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization
PLoS Medicine
2019-04-02
194 citations
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
New England Journal of Medicine
2019-03-13
387 citations
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
Trials
2019-01-16
29 citations
Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum
The Journal of Clinical Pharmacology
2018-10-25
11 citations
Efavirenz Pharmacokinetics during Pregnancy and Infant Washout
Antiviral Therapy
2018-02-01
22 citations
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
Frontiers in Pharmacology
2016-08-04
19 citations
Maraviroc Pharmacokinetics in HIV-1–Infected Pregnant Women
Clinical Infectious Diseases
2015-07-22
16 citations
Raltegravir pharmacokinetics during pregnancy.
2014-12-01
55 citations
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy.
2014-09-25
7 citations